David Mountcastle - 05 Jan 2022 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role
Chief Financial Officer
Signature
/s/ Thomas Bartrum, attorney-in-fact
Issuer symbol
PRVA
Transactions as of
05 Jan 2022
Net transactions value
-$375,321
Form type
4
Filing time
07 Jan 2022, 15:24:15 UTC
Previous filing
23 Dec 2021
Next filing
20 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRVA Common Stock, $0.01 par value per share Options Exercise $43,108 +21,554 +94% $2.00* 44,380 05 Jan 2022 Direct
transaction PRVA Common Stock, $0.01 par value per share Sale $418,429 -16,391 -37% $25.53 27,989 05 Jan 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRVA Stock Option (Right to Purchase) Options Exercise $0 -21,554 -17% $0.000000 107,774 05 Jan 2022 Common Stock 21,554 $2.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

David Mountcastle is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.96 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
F3 These stock options to purchase shares of common stock of the Issuer were granted under the Second Amended and Restated PH Group Parent Corp. Stock Option Plan. 62,508 of the stock options are fully vested and exercisable. The remaining stock options vest as follows: 10,778 vest on April 1, 2022, 17,244 vest on April 29, 2022 and 17,244 vest on October 29, 2022.